Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
2.500
-0.050 (-1.96%)
At close: Apr 17, 2026, 4:00 PM EDT
2.578
+0.078 (3.13%)
After-hours: Apr 17, 2026, 7:51 PM EDT
Organogenesis Holdings Market Cap
Organogenesis Holdings has a market cap or net worth of $321.6 million as of April 17, 2026. Its market cap has decreased by -41.71% in one year.
Market Cap
321.60M
Enterprise Value
307.82M
1-Year Change
-41.71%
Ranking
Category
Stock Price
$2.50
Market Cap Chart
Since January 8, 2019, Organogenesis Holdings's market cap has decreased from $1.24B to $321.60M, a decrease of -73.99%. That is a compound annual growth rate of -16.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 321.60M | -51.08% |
| Dec 31, 2025 | 657.40M | 63.40% |
| Dec 31, 2024 | 402.32M | -25.09% |
| Dec 29, 2023 | 537.07M | 52.51% |
| Dec 30, 2022 | 352.16M | -70.37% |
| Dec 31, 2021 | 1.19B | 23.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Esperion Therapeutics | 523.89M |
| Kamada | 486.21M |
| Emergent BioSolutions | 454.99M |
| Canopy Growth | 437.34M |
| Akebia Therapeutics | 376.37M |
| SIGA Technologies | 341.03M |
| Evolus | 305.13M |
| Anika Therapeutics | 214.41M |